Delay of 6 weeks between aprotinin injections for tendinopathy reduces risk of allergic reaction

Alfredson, 1998, Heavy-load eccentric calf-muscle training for the treatment of chronic Achilles tendinosis, Am J Sports Med, 26, 360, 10.1177/03635465980260030301 Roos, 2004, Clinical improvement after 6 weeks of eccentric exercise in patients with mid-portion Achilles tendinopathy—a randomized trial with 1-year follow-up, Scand J Med Sci Sports, 14, 286, 10.1111/j.1600-0838.2004.378.x Paoloni, 2004, Topical glyceryl trinitrate treatment of chronic noninsertional achilles tendinopathy. A randomized, double-blind, placebo-controlled trial, J Bone Joint Surg Am, 86A, 916, 10.2106/00004623-200405000-00005 Paoloni, 2003, Topical nitric oxide application in the treatment of chronic extensor tendinosis at the elbow: a randomized, double-blinded, placebo-controlled clinical trial, Am J Sports Med, 31, 915, 10.1177/03635465030310062901 Alfredson, 2005, Neovascularisation in chronic painful patellar tendinosis—promising results after sclerosing neovessels outside the tendon challenge the need for surgery, Knee Surg Sports Traumatol Arthrosc, 13, 74, 10.1007/s00167-004-0549-x van der Windt, 2002, Are corticosteroid injections as effective as physiotherapy for the treatment of a painful shoulder?, 289 Speed, 2001, Corticosteroid injections in tendon lesions, Br Med J, 323, 382, 10.1136/bmj.323.7309.382 Santini, 2002, How should you treat tennis elbow?, 351 Bisset, 2006, Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial, Br Med J, 333, 939, 10.1136/bmj.38961.584653.AE Cook, 2002, What is the most appropriate treatment for patellar tendinopathy?, 422 McLauchlan G, Handoll H. Interventions for treating acute and chronic Achilles tendinitis. The Cochrane Database of Systematic Reviews; 2001 [CD000232]. Shrier, 1996, Achilles tendonitis: are corticosteroid injections useful or harmful?, Clin J Sport Med, 6, 218, 10.1097/00042752-199610000-00007 Bojanov, 2005, Aprotinin—an update for the perioperative physician, Ann Cardiothorac Anaesth, 8, 75, 10.4103/0971-9784.37961 Komurcu, 1997, Reduction of restrictive adhesions by local aprotinin application and primary sheath repair in surgically traumatized flexor tendons of the rabbit, J Hand Surg [Am], 22, 826, 10.1016/S0363-5023(97)80076-7 Dollery, 1991 Chu, 2005, Regulation of gelatinases expression by cytokines, endotokin, and pharmacological agents in the human osteoarthritic knee, Connect Tissue Res, 45, 142, 10.1080/03008200490506058 Lee, 1996, Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1 synthesis by plasminogen in clutured human vascular smooth muscle cells, Circ Res, 78, 44, 10.1161/01.RES.78.1.44 Fu, 2002, Increased expression of matrix metalloproteinase 1 (MMP1) in 11 patients with patellar tendinosis, Acta Orthop Scand, 73, 658, 10.1080/000164702321039624 Ireland, 2001, Multiple changes in gene expression in chronic human Achilles tendinopathy, Matrix Biol, 20, 159, 10.1016/S0945-053X(01)00128-7 Alfredson, 2003, cDNA-arrays and real time quantitative PCR techniques in the investigation of chronic human Achilles tendinopathy, J Orthop Res, 21, 970, 10.1016/S0736-0266(03)00107-4 Lo, 2004, Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase mRNA levels are specifically altered in torn rotator cuff tendons, Am J Sports Med, 32, 1223, 10.1177/0363546503262200 Arnoczky S, Lavagnino M, Egerbacher M, Caballero O, Gardner K. Matrix metalloproteinase inhibitors prevent a decrease in the mechanical properties of stree-deprived tendons. Am J Sports Med; in press. doi:10.1177/0363546506296043. Tumber, 2003, The effects of serine proteinase inhibitors on bone resorption in vitro, J Endocrinol, 178, 437, 10.1677/joe.0.1780437 Geudj E. La tendinite achilleenne chez jeune sportif. [MD Thesis]; 1973. Genety, 1971, Utilisation du Zymofren dans le traitment des tendinities chez le sportif, Cah Med Lyon, 47, 135 Capasso, 1997, Aprotinin, corticosteroids and normosaline in the management of patellar tendinopathy in athletes: a prospective randomized study, Sports Exerc Inj, 3, 111 Maffulli, 2004, Calcific insertional Achilles tendinopathy. Reattachment with bone anchors, Am J Sports Med, 32, 174, 10.1177/0363546503258923 Brown, 2006, Aprotinin in the management of Achilles tendinopathy: a randomised controlled trial, Br J Sports Med, 40, 275, 10.1136/bjsm.2005.021931 Capasso, 1993, Preliminary results with peritendinous potease inhibitor injections in the management of Achilles tendinitis, J Sports Traumatol Rel Res, 15, 37 Aubin, 1997, Case report of aprotinin in Achilles tendinopathies with athletes (French), J Pharm Clin, 16, 270 Orchard, 2005, The risks of local aprotinin injections for treating chronic tendinopathy, Sport Health, 23, 24 Rochcongar, 2005, Tendinopathie calcanéenne et sport: place des injections d’aprotinin, Sci Sports, 20, 261, 10.1016/j.scispo.2005.07.002 Beierlein, 2005, Forty years of clinical aprotinin use: a review of 124 hypersensitivity reactions, Ann Thorac Surg, 79, 741, 10.1016/j.athoracsur.2004.03.072 Dietrich, 2001, Anaphylactic reactions to aprotinin reexposure in cardiac surgery, Anesthesiology, 95, 64, 10.1097/00000542-200107000-00015 Shirai, 2005, Anaphylaxis to aprotinin in fibrin sealant, Intern Med, 44, 1088, 10.2169/internalmedicine.44.1088 Rukin, 2007, Systemic allergic reactions to aprotinin injection around the Achilles tendon, J Sci Med Sport, 10, 320, 10.1016/j.jsams.2006.07.007 Tinkelman, 1995, Immunotherapy: a 1-year prospective study to evaluate risk factors of systemic reactions, J Allergy Clin Immunol, 95 Kay, 1997 Scheule, 2000, The significance of preformed aprotinin-specific antibodies in cardiosurgical patients, Anesth Analg, 90, 262, 10.1213/00000539-200002000-00005 Apeler, 2004, Expression, purification, biochemical and pharmacological characterization of a recombinant aprotinin variant, Arzneimittelforschung, 54, 483